Literature DB >> 14624182

Comparison of response to fluvoxamine in nondemented elderly compared to younger patients affected by major depression.

Raffaella Zanardi1, Cristina Cusin, David Rossini, Diana De Ronchi, Alessandro Serretti.   

Abstract

Although it is well established that the diagnosis and treatment of depression in the elderly are major health care problems, the relative efficacy of antidepressant treatment in the elderly compared with younger adults has not been definitively established. In this study, we analyzed antidepressant response in 528 nondemented consecutive inpatients affected by a major depressive episode. The sample was divided based on a cut-off of 60 years (< or = 60 n = 354; mean age 46.6 +/- 10.4 years; > 60 n = 174; mean age 66.1 +/- 4.2 years); all the patients were treated with fluvoxamine for at least 6 weeks and they were assessed weekly by using the Hamilton Rating Scale for Depression. Fluvoxamine proved to be effective in our elderly sample, even if antidepressant response was lower in the elderly compared with that of younger subjects (chi2 = 6.27, P = 0.01). Moreover, when compared with younger subjects, the older ones showed significantly slower reduction of depressive symptoms (P = 0.0006). This difference between the 2 age groups was evident since the 2nd week of treatment, and it appeared to be independent of other clinical variables.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14624182     DOI: 10.1097/01.jcp.0000095344.32154.d3

Source DB:  PubMed          Journal:  J Clin Psychopharmacol        ISSN: 0271-0749            Impact factor:   3.153


  4 in total

1.  Cognitive improvement following treatment in late-life depression: relationship to vascular risk and age of onset.

Authors:  Deanna M Barch; Gina DʼAngelo; Carl Pieper; Consuelo H Wilkins; Kathleen Welsh-Bohmer; Warren Taylor; Keith S Garcia; Kenneth Gersing; P Murali Doraiswamy; Yvette I Sheline
Journal:  Am J Geriatr Psychiatry       Date:  2012-08       Impact factor: 4.105

Review 2.  Course and outcomes of depression in the elderly.

Authors:  Robert Kohn; Gary Epstein-Lubow
Journal:  Curr Psychiatry Rep       Date:  2006-02       Impact factor: 5.285

3.  Adjuvant pioglitazone for unremitted depression: Clinical correlates of treatment response.

Authors:  Kathleen Watson Lin; Tonita E Wroolie; Thalia Robakis; Natalie L Rasgon
Journal:  Psychiatry Res       Date:  2015-10-22       Impact factor: 3.222

4.  Identification of an optimal dose of intravenous ketamine for late-life treatment-resistant depression: a Bayesian adaptive randomization trial.

Authors:  Marijn Lijffijt; Nicholas Murphy; Sidra Iqbal; Charles E Green; Tabish Iqbal; Lee C Chang; Colin N Haile; Lorna C Hirsch; Nithya Ramakrishnan; Dylan A Fall; Alan C Swann; Rayan K Al Jurdi; Sanjay J Mathew
Journal:  Neuropsychopharmacology       Date:  2021-11-27       Impact factor: 8.294

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.